13 employees
Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis.
2016
$35M
from 4 investors over 4 rounds
Candesant Biomedical raised $35M on June 6, 2023
Investors: Correlation Ventures, KCK Medtech and Polaris Partners
Candesant Biomedical raised $9.1M on February 5, 2019
Investors: Polaris Partners